tiprankstipranks
Serina Therapeutics (SER)
:SER
US Market
SER
Serina Therapeutics
RESEARCH TOOLSreports
Want to see SER full AI Analyst Report?

Serina Therapeutics (SER) Income Statement

257 Followers

Serina Therapeutics Income Statement

Last quarter (Q4 2025), Serina Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Serina Therapeutics's net income was $-3.34M. See Serina Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 130.00K$ 56.00K$ 3.15M$ 500.00K$ 3.46M
Gross Profit
$ 45.00K$ -138.00K$ 3.06M$ 500.00K$ -333.84K
Operating Expenses
$ 24.02M$ 16.91M$ 6.19M$ 2.77M$ 1.30M
Depreciation and Amortization
$ 85.00K$ 194.00K$ 90.00K$ 61.27K$ 33.37K
EBITDA
$ -24.02M$ -10.49M$ 5.92M$ -2.60M$ -1.23M
Operating Income
$ -24.02M$ -17.05M$ -3.13M$ -2.27M$ -1.63M
Other Income/Expenses
$ 4.83M$ 5.84M$ 8.40M$ -411.74K$ 366.81K
Pretax Income
$ -19.20M$ -11.21M$ 5.27M$ -2.68M$ -1.26M
Net Income
$ -19.18M$ -11.14M$ 5.27M$ -2.68M$ -1.26M
Per Share Metrics
Basic EPS
$ -1.91$ -1.51$ 0.63$ -2.49$ -0.59
Diluted EPS
$ -1.91$ -1.51$ 0.63$ -2.49$ -0.59
Weighted Average Shares Outstanding
 10.19M 7.36M 8.41M 1.08M 1.08M
Weighted Average Shares Outstanding (Diluted)
 10.19M 7.36M 8.41M 1.08M 1.08M
Currency in USD

Serina Therapeutics Earnings and Revenue History